EVERYTHING ABOUT AGO TUMOR

The corresponding relative risk reduction is rather depending on the tumor biology than on the nodal status and extent of disease [62].Germline screening for hereditary breast and ovarian cancer has become ever more related not just for risk-tailored prevention actions but in addition for therapeutic decision making. While using the rising quantity